Ma Teng-Hui, Yuan Zi-Xu, Zhong Qing-Hua, Wang Huai-Ming, Qin Qi-Yuan, Chen Xiao-Xia, Wang Jian-Ping, Wang Lei
Teng-Hui Ma, Zi-Xu Yuan, Qing-Hua Zhong, Huai-Ming Wang, Qi-Yuan Qin, Xiao-Xia Chen, Jian-Ping Wang, Lei Wang, Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510655, Guangdong Province, China.
World J Gastroenterol. 2015 Mar 28;21(12):3593-8. doi: 10.3748/wjg.v21.i12.3593.
To assess the efficacy and safety of a modified topical formalin irrigation method in refractory hemorrhagic chronic radiation proctitis (CRP).
Patients with CRP who did not respond to previous medical treatments and presented with grade II-III rectal bleeding according to the Common Terminology Criteria for Adverse Events were enrolled. Patients with anorectal strictures, deep ulcerations, and fistulas were excluded. All patients underwent flexible endoscopic evaluation before treatment. Patient demographics and clinical data, including primary tumor, radiotherapy and previous treatment options, were collected. Patients received topical 4% formalin irrigation in a clasp-knife position under spinal epidural anesthesia in the operating room. Remission of rectal bleeding and related complications were recorded. Defecation, remission of bleeding, and other symptoms were investigated at follow-up. Endoscopic findings in patients with rectovaginal fistulas were analyzed.
Twenty-four patients (19 female, 5 male) with a mean age of 61.5 ± 9.5 years were enrolled. The mean time from the end of radiotherapy to the onset of bleeding was 11.1 ± 9.0 mo (range: 2-24 mo). Six patients (25.0%) were blood transfusion dependent. The median preoperative Vienna Rectoscopy Score (VRS) was 3 points. Nineteen patients (79.2%) received only one course of topical formalin irrigation, and five (20.8%) required a second course. No side effects were observed. One month after treatment, bleeding cessation was complete in five patients and obvious in 14; the effectiveness rate was 79.1% (19/24). For long-term efficacy, 5/16, 1/9 and 0/6 patients complained of persistent bleeding at 1, 2 and 5 years after treatment, respectively. Three rectovaginal fistulas were found at 1 mo, 3 mo and 2 years after treatment. Univariate analysis showed associations of higher endoscopic VRS and ulceration score with risk of developing rectovaginal fistula.
Modified formalin irrigation is an effective and safe method for hemorrhagic CRP, but should be performed cautiously in patients with a high endoscopic VRS.
评估改良局部福尔马林灌注法治疗难治性出血性慢性放射性直肠炎(CRP)的疗效和安全性。
纳入对先前药物治疗无反应且根据不良事件通用术语标准表现为II - III级直肠出血的CRP患者。排除有肛门直肠狭窄、深度溃疡和瘘管的患者。所有患者在治疗前均接受了软性内镜评估。收集患者的人口统计学和临床数据,包括原发肿瘤、放疗及先前的治疗方案。患者在手术室接受脊髓硬膜外麻醉下呈折刀位的局部4%福尔马林灌注。记录直肠出血缓解情况及相关并发症。随访时调查排便、出血缓解及其他症状。分析直肠阴道瘘患者的内镜检查结果。
纳入24例患者(19例女性,5例男性),平均年龄61.5±9.5岁。从放疗结束至出血发生的平均时间为11.1±9.0个月(范围:2 - 24个月)。6例患者(25.0%)依赖输血。术前维也纳直肠镜评分(VRS)中位数为3分。19例患者(79.2%)仅接受了一个疗程的局部福尔马林灌注,5例(20.8%)需要第二个疗程。未观察到副作用。治疗1个月后,5例患者出血完全停止,14例明显缓解;有效率为79.1%(19/24)。对于长期疗效,治疗后1年、2年和5年分别有5/16、1/9和0/6例患者主诉持续出血。治疗后1个月、3个月和2年发现3例直肠阴道瘘。单因素分析显示内镜VRS和溃疡评分较高与发生直肠阴道瘘的风险相关。
改良福尔马林灌注是治疗出血性CRP的有效且安全的方法,但对于内镜VRS较高的患者应谨慎使用。